Published in Curr Biol on October 02, 2001
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell (2008) 14.17
Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell (2008) 12.29
Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol (2010) 9.35
Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature (2011) 9.33
Nanog is the gateway to the pluripotent ground state. Cell (2009) 7.27
Induction of human neuronal cells by defined transcription factors. Nature (2011) 6.84
iPS cells produce viable mice through tetraploid complementation. Nature (2009) 6.51
Nuclear reprogramming to a pluripotent state by three approaches. Nature (2010) 5.26
Epigenetic reprogramming and induced pluripotency. Development (2009) 4.90
Induced pluripotency: history, mechanisms, and applications. Genes Dev (2010) 4.89
Epigenetic inheritance during the cell cycle. Nat Rev Mol Cell Biol (2009) 4.43
Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell (2011) 3.62
Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature (2009) 3.43
Direct lineage conversions: unnatural but useful? Nat Biotechnol (2011) 2.69
Microfluidic control of cell pairing and fusion. Nat Methods (2009) 2.58
T-cell factor 3 regulates embryonic stem cell pluripotency and self-renewal by the transcriptional control of multiple lineage pathways. Stem Cells (2008) 2.43
Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev (2009) 2.40
Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Mol Biol Cell (2007) 2.31
Pluripotent stem cell lines. Genes Dev (2008) 2.25
Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell (2012) 2.15
Epigenetic programming and reprogramming during development. Nat Struct Mol Biol (2013) 2.13
Different roles for Tet1 and Tet2 proteins in reprogramming-mediated erasure of imprints induced by EGC fusion. Mol Cell (2013) 2.10
Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2. PLoS Genet (2008) 2.01
Disclosing hidden transcripts: mouse natural sense-antisense transcripts tend to be poly(A) negative and nuclear localized. Genome Res (2005) 1.85
Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci (2008) 1.82
Molecular roadblocks for cellular reprogramming. Mol Cell (2012) 1.74
Controlled differentiation of stem cells. Adv Drug Deliv Rev (2007) 1.72
The transcriptome of human oocytes. Proc Natl Acad Sci U S A (2006) 1.70
Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers. Philos Trans R Soc Lond B Biol Sci (2013) 1.70
Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Biol Cell (2005) 1.69
G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells. Stem Cells (2008) 1.68
Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol Cell Biol (2004) 1.67
A blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res (2013) 1.50
Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. Cancer Res (2009) 1.46
Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev (2010) 1.43
Biomedical Application of Dental Tissue-Derived Induced Pluripotent Stem Cells. Stem Cells Int (2016) 1.42
Active tissue-specific DNA demethylation conferred by somatic cell nuclei in stable heterokaryons. Proc Natl Acad Sci U S A (2007) 1.40
Reversine increases the plasticity of lineage-committed mammalian cells. Proc Natl Acad Sci U S A (2007) 1.39
Embryonic stem cell differentiation: a chromatin perspective. Reprod Biol Endocrinol (2003) 1.37
Recent advancements in cloning by somatic cell nuclear transfer. Philos Trans R Soc Lond B Biol Sci (2013) 1.33
Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional. FASEB J (2009) 1.31
High-efficiency stem cell fusion-mediated assay reveals Sall4 as an enhancer of reprogramming. PLoS One (2008) 1.26
Genetic control of wayward pluripotent stem cells and their progeny after transplantation. Cell Stem Cell (2009) 1.26
The biology of head and neck cancer stem cells. Oral Oncol (2011) 1.25
Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair. Circ Res (2008) 1.25
Innovation in the culture and derivation of pluripotent human stem cells. Curr Opin Biotechnol (2008) 1.18
Tpt1 activates transcription of oct4 and nanog in transplanted somatic nuclei. Curr Biol (2007) 1.17
A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol (2016) 1.16
Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging. J R Soc Interface (2010) 1.16
X-inactivation and X-reactivation: epigenetic hallmarks of mammalian reproduction and pluripotent stem cells. Hum Genet (2011) 1.14
DNA synthesis is required for reprogramming mediated by stem cell fusion. Cell (2013) 1.14
Embryonic stem cells induce pluripotency in somatic cell fusion through biphasic reprogramming. Mol Cell (2012) 1.14
iPS cell technologies: significance and applications to CNS regeneration and disease. Mol Brain (2014) 1.14
Defining hypo-methylated regions of stem cell-specific promoters in human iPS cells derived from extra-embryonic amnions and lung fibroblasts. PLoS One (2010) 1.11
From stealing fire to cellular reprogramming: a scientific history leading to the 2012 Nobel Prize. Stem Cell Reports (2013) 1.10
Histone variant macroH2A marks embryonic differentiation in vivo and acts as an epigenetic barrier to induced pluripotency. J Cell Sci (2012) 1.10
Direct lineage reprogramming to neural cells. Curr Opin Neurobiol (2012) 1.08
Long noncoding RNAs: new players in the molecular mechanism for maintenance and differentiation of pluripotent stem cells. Stem Cells Dev (2013) 1.07
Instructing an embryonic stem cell-derived oocyte fate: lessons from endogenous oogenesis. Endocr Rev (2009) 1.06
Dielectrophoretic cell trapping and parallel one-to-one fusion based on field constriction created by a micro-orifice array. Biomicrofluidics (2010) 1.05
Effective cardiac myocyte differentiation of human induced pluripotent stem cells requires VEGF. PLoS One (2013) 1.05
H3K9 histone acetylation predicts pluripotency and reprogramming capacity of ES cells. Nucleus (2011) 1.04
The X-inactivation trans-activator Rnf12 is negatively regulated by pluripotency factors in embryonic stem cells. Hum Genet (2011) 1.04
Reprogrammed gene expression in a somatic cell-free extract. EMBO Rep (2002) 1.03
Rapid induction of pluripotency genes after exposure of human somatic cells to mouse ES cell extracts. Exp Cell Res (2008) 1.03
Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells. Stem Cells Dev (2011) 1.03
Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Cancer Res (2011) 1.02
Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells. PLoS One (2010) 1.02
Tsix RNA and the germline factor, PRDM14, link X reactivation and stem cell reprogramming. Mol Cell (2013) 1.01
Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning Stem Cells (2009) 1.00
Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol (2015) 1.00
Epigenetic reprogramming in the germline: towards the ground state of the epigenome. Philos Trans R Soc Lond B Biol Sci (2011) 0.99
Reactivation of the inactive X chromosome in development and reprogramming. Cell Mol Life Sci (2012) 0.98
Stem cells for heart cell therapies. Tissue Eng Part B Rev (2008) 0.98
Pluripotency factor binding and Tsix expression act synergistically to repress Xist in undifferentiated embryonic stem cells. Epigenetics Chromatin (2011) 0.97
The aging signature: a hallmark of induced pluripotent stem cells? Aging Cell (2013) 0.96
Quantitative proteome analysis of pluripotent cells by iTRAQ mass tagging reveals post-transcriptional regulation of proteins required for ES cell self-renewal. Mol Cell Proteomics (2010) 0.96
T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications. Proc Natl Acad Sci U S A (2011) 0.94
Concise review: Pluripotency and the transcriptional inactivation of the female Mammalian X chromosome. Stem Cells (2012) 0.94
Immunogenicity of human embryonic stem cells: can we achieve tolerance? Springer Semin Immunopathol (2004) 0.93
Cellular reprogramming. Cold Spring Harb Perspect Biol (2014) 0.92
Efficiencies and mechanisms of nuclear reprogramming. Cold Spring Harb Symp Quant Biol (2010) 0.92
The pluripotency factor-bound intron 1 of Xist is dispensable for X chromosome inactivation and reactivation in vitro and in vivo. Cell Rep (2013) 0.92
Recipient cell nuclear factors are required for reprogramming by nuclear transfer. Development (2010) 0.91
Generation of primordial germ cells from pluripotent stem cells. Differentiation (2009) 0.91
Proteomic-based identification of maternal proteins in mature mouse oocytes. BMC Genomics (2009) 0.91
Transient in vitro epigenetic reprogramming of skin fibroblasts into multipotent cells. Biomaterials (2009) 0.90
H3K27 trimethylation is an early epigenetic event of p16INK4a silencing for regaining tumorigenesis in fusion reprogrammed hepatoma cells. J Biol Chem (2010) 0.90
Ekiden to iPS Cells. Nat Med (2009) 0.89
Transcription elongation factor Tcea3 regulates the pluripotent differentiation potential of mouse embryonic stem cells via the Lefty1-Nodal-Smad2 pathway. Stem Cells (2013) 0.89
Systematic identification of cis-silenced genes by trans complementation. Hum Mol Genet (2008) 0.88
Cloning and Characterization of 3.1kb Promoter Region of the Oct4 Gene from the Fischer 344 Rat. Open Stem Cell J (2009) 0.88
Embryonic stem cells contribute to mouse chimeras in the absence of detectable cell fusion. Cloning Stem Cells (2008) 0.88
Thinking outside the liver: induced pluripotent stem cells for hepatic applications. World J Gastroenterol (2013) 0.88
Pluripotent stem cells and gene therapy. Transl Res (2013) 0.88
Using heterokaryons to understand pluripotency and reprogramming. Philos Trans R Soc Lond B Biol Sci (2011) 0.87
Electrofusion of mesenchymal stem cells and islet cells for diabetes therapy: a rat model. PLoS One (2013) 0.87
Culture conditions for bovine embryonic stem cell-like cells isolated from blastocysts after external fertilization. Cytotechnology (2012) 0.87
The Mbd1-Atf7ip-Setdb1 pathway contributes to the maintenance of X chromosome inactivation. Epigenetics Chromatin (2014) 0.87
Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature (1995) 11.06
Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. Dev Biol (2001) 5.64
Two distinct types of helper T cells involved in the secondary antibody response: independent and synergistic effects of Ia- and Ia+ helper T cells. J Exp Med (1978) 3.80
Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice. Dev Growth Differ (1999) 3.56
Regulation of homocytotropic antibody formation in the rat. VI. Inhibitory effect of thymocytes on the homocytotropic antibody response. J Immunol (1971) 3.48
Properties of primed suppressor T cells and their products. Transplant Rev (1975) 3.42
A glycolipid on the surface of mouse natural killer cells. Eur J Immunol (1980) 3.13
A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Dev Biol (1999) 3.11
The role of antigen-specific T cell factors in the immune response. Adv Immunol (1979) 2.95
Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis (1977) 2.80
Properties of antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. I. In vivo activity and immunochemical characterization. J Exp Med (1975) 2.78
Normal and abnormal regulation of beta-msh in man. J Clin Invest (1969) 2.68
Distribution of gamma E-forming cells in lymphoid tissues of the human and monkey. J Immunol (1970) 2.66
Regulation of homocytotropic antibody formation in the rat. 3. Effect of thymectomy and splenectomy. J Immunol (1971) 2.61
Rac1 is required for the formation of three germ layers during gastrulation. Oncogene (1998) 2.61
Selective roles of thymus-derived lymphocytes in the antibody response. I. Differential suppressive effect of carrier-primed T cells on hapten-specific IgM and IgG antibody responses. J Exp Med (1974) 2.50
Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest (2000) 2.45
Radioimmunoassay of beta-MSH in human plasma and tissues. J Clin Invest (1967) 2.44
Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol (2001) 2.42
Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J (1997) 2.34
Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis (2001) 2.30
Antigen-specific suppressive factor produced by a transplantable I-J bearing T-cell hybridoma. Nature (1979) 2.28
Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol (1998) 2.25
Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol (1990) 2.18
Clinical and laboratory studies of ectopic humoral syndromes. Recent Prog Horm Res (1969) 2.16
Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. III. Dual gene control of the T-cell-mediated suppression of the antibody response. J Exp Med (1976) 2.12
Properties of antigen-specific suppressive T cell factor in the regulation of antibody response of the mouse. II. In vitro activity and evidence for the I region gene product. J Immunol (1976) 2.12
Negative selection of CD4+CD8+ thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J Exp Med (1994) 1.97
Morphological change in the early stages of the mating process of Rhodosporidium toruloides. J Bacteriol (1975) 1.93
Accuracy and performance of the Terumo ES-H51, a new portable blood pressure monitor. Am J Hypertens (1994) 1.92
Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke (1997) 1.91
Cloning of inv, a gene that controls left/right asymmetry and kidney development. Nature (1998) 1.90
Studies on passive serum sickness. II. Factors determining the localization of antigen-antibody complexes in the murine renal glomerulus. Lab Invest (1978) 1.89
Functional and molecular organisation of an antigen-specific suppressor factor from a T-cell hybridoma. Nature (1980) 1.84
Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A (1999) 1.84
Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene. J Exp Med (1989) 1.83
A mouse embryonic stem cell line showing pluripotency of differentiation in early embryos and ubiquitous beta-galactosidase expression. Cell Differ Dev (1990) 1.79
Regulation of reaginic antibody formation in animals. Prog Allergy (1975) 1.78
The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis (1993) 1.77
A cDNA clone closely associated with non-A, non-B hepatitis. Nucleic Acids Res (1990) 1.76
Rapid translocation of cytosolic Ca2+/calmodulin-dependent protein kinase II into postsynaptic density after decapitation. J Neurochem (1994) 1.73
Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans. Calcif Tissue Int (1993) 1.72
Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy. J Am Soc Nephrol (1997) 1.71
Specific enrichment of the suppressor T cell bearing I-J determinants: parallel functional and serological characterizations. J Exp Med (1977) 1.70
Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol (1984) 1.70
A role for pref-1 and HES-1 in thymocyte development. J Immunol (2000) 1.70
Purification and physicochemical characterization of murine T cell replacing factor (TRF). J Immunol (1985) 1.67
Establishment of embryonic stem cell lines from cynomolgus monkey blastocysts produced by IVF or ICSI. Dev Dyn (2001) 1.65
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Regulation of homocytotropic antibody formation in the rat. II. Effect of X-irradiation. J Immunol (1971) 1.65
Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity (1998) 1.63
Studies on passive serum sickness. I. The glomerular fine structure of serum sickness nephritis induced by preformed antigen-antibody complexes in the mouse. Lab Invest (1971) 1.63
Identification of the duplicated segments in rice chromosomes 1 and 5 by linkage analysis of cDNA markers of known functions. Theor Appl Genet (1994) 1.63
Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab (1998) 1.62
New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat Med (1999) 1.62
Regulation of homocytotropic antibody formation in the rat. 8. An antigen-specific T cell factor that regulates anti-hapten homocytotropic antibody response. J Immunol (1973) 1.61
CD69 cell surface expression identifies developing thymocytes which audition for T cell antigen receptor-mediated positive selection. Int Immunol (1993) 1.60
Participation of macrophages in segmental endocapillary proliferation preceding focal glomerular sclerosis. J Pathol (1993) 1.60
Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J Neurosci (2000) 1.59
Differential cytotoxic effect of natural thymocytotoxic autoantibody of NZB mice on functional subsets of T cells. J Immunol (1978) 1.58
The paternal methylation imprint of the mouse H19 locus is acquired in the gonocyte stage during foetal testis development. Genes Cells (2000) 1.56
Regulation of homocytotropic antibody formation in the rat. I. Feed-back regulation by passively administered antibody. J Immunol (1971) 1.55
Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart (2005) 1.55
Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int J Dev Biol (1994) 1.55
Intraglomerular C3 synthesis in human kidney detected by in situ hybridization. J Am Soc Nephrol (1996) 1.54
The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis. Clin Endocrinol (Oxf) (1997) 1.54
The assignment of chain specificities for anti-Ia monoclonal antibodies using L cell transfectants. J Immunol (1986) 1.54
RNA transcripts for I-J polypeptides are apparently not encoded between the I-A and I-E subregions of the murine major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 1.54
Endoderm-specific gene expression in embryonic stem cells differentiated to embryoid bodies. Exp Cell Res (1996) 1.52
Delayed and selective motor neuron death after transient spinal cord ischemia: a role of apoptosis? J Thorac Cardiovasc Surg (1998) 1.52
Autonomous transition into meiosis of mouse fetal germ cells in vitro and its inhibition by gp130-mediated signaling. Dev Biol (2001) 1.50
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc Natl Acad Sci U S A (1994) 1.49
Producing a full-scale model from computed tomographic data with the rapid prototyping technique using the binder jet method: a comparison with the laser lithography method using a dry skull. J Craniofac Surg (2000) 1.48
Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development. Mol Cell Biol (1995) 1.47
T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6. EMBO J (1997) 1.47
Two Japanese CADASIL families with a R141C mutation in the Notch3 gene. Intern Med (2001) 1.46
T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc Natl Acad Sci U S A (1999) 1.46
Selective roles of thymus-derived lymphocytes in the antibody response. II. Preferential suppression of high-affinity antibody-forming cells by carrier-primed suppressor T cells. J Exp Med (1974) 1.46
Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid. Br J Psychiatry (1994) 1.45
Salivary bisphenol-A levels detected by ELISA after restoration with composite resin. J Mater Sci Mater Med (2005) 1.45
Intentional body clipping of wide-necked basilar artery bifurcation aneurysms. J Neurosurg (2000) 1.45
Comparison of duodenal stent placement with surgical gastrojejunostomy for palliation in patients with duodenal obstructions caused by pancreaticobiliary malignancies. Endoscopy (2004) 1.45
Usefulness of endoscopic retrograde biliary biopsy using large-capacity forceps for extrahepatic biliary strictures: a prospective randomized study. Endoscopy (2010) 1.45
IP(3) receptor type 3 and PLCbeta2 are co-expressed with taste receptors T1R and T2R in rat taste bud cells. Chem Senses (2001) 1.44
Half-lives of two types of rat homocytotropic antibodies in circulation and in the skin. Int Arch Allergy Appl Immunol (1975) 1.44
Undiminished regulatory T cells in the thymus of patients with myasthenia gravis. Neurology (2010) 1.43
Cautions after liver transplantation for familial amyloidotic polyneuropathy. Intern Med (2001) 1.43
Double aneurysms at distal basilar artery: report of nine cases. Neurosurgery (2000) 1.43
Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun (2000) 1.43
Regulation of homocytotropic antibody formation in the rat. IX. Further characterization of the antigen-specific inhibitory T cell factor in hapten-specific homocytotropic antibody response. J Immunol (1974) 1.42
FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. II. Structure determination. J Antibiot (Tokyo) (1994) 1.41
Improvement of SSPE by intrathecal infusion of alpha-IFN. Neurology (2004) 1.40
Establishment of a local cooling model against spinal cord ischemia representing prolonged induction of heat shock protein. J Thorac Cardiovasc Surg (2001) 1.40
Myositis as a manifestation of chronic graft-versus-host disease. Intern Med (2000) 1.40
Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients. J Gastroenterol (1998) 1.39
Regulation of homocytotropic antibody formation in the rat. V, Cell cooperation in the anti-hapten homocytotropic antibody response. J Immunol (1971) 1.38
Surgical dissemination of intracranial xanthogranulomas. Case illustration. J Neurosurg (2001) 1.38
Dependence of Dbl and Dbs transformation on MEK and NF-kappaB activation. Mol Cell Biol (1999) 1.38